Results 61 to 70 of about 86,213 (145)
ABSTRACT The clinical significance of PNH Type II white blood cells (WBCs) remains unclear. We assessed the relative percentage (rel%) of Type II neutrophils in 355 patients with a PNH clone ≥ 1% on neutrophils enrolled by 33 flow cytometry laboratories in the 5‐year French nation‐wide multicenter prospective observational study.
Orianne Wagner‐Ballon +41 more
wiley +1 more source
Acquired Aplastic Anaemia and Paroxysmal Nocturnal Haemoglobinuria
Aplastic anaemia (AA) is a rare bone marrow failure characterised by pancytopenia and a hypocellular bone marrow. Although AA is commonly acquired, idiopathic and immune mediated, late onset inherited AA secondary to DNA repair defects, telomere ...
Neal S Young +7 more
core +1 more source
International Journal of Laboratory Hematology, EarlyView.
Fatma AlBulushi, Eric McGinnis
wiley +1 more source
ABSTRACT Post‐translational modifications (PTMs) of proteins are essential to maintain homeostasis as many cellular processes rely on reversible PTMs. However, several PTMs, particularly irreversible PTMs in the extracellular space, can contribute to tissue dysfunction, inflammation, and may even trigger the development of autoimmunity against PTM ...
Marleen M. J. van Greevenbroek +1 more
wiley +1 more source
ABSTRACT Fungal infections in Asia are influenced by warm, humid climates, high population density and expanding healthcare systems, which together facilitate the emergence, transmission and detection of both common and rare pathogens. While Candida and Aspergillus species remain the leading causes of invasive fungal disease, increasing attention has ...
Narut Chancharussin +3 more
wiley +1 more source
ABSTRACT Severe aplastic anemia (SAA) is a serious medical condition that is characterized by its abrupt onset, rapid progression of the disease, and alarmingly high mortality rate, making it a significant concern in the field of hematology. Intensive immunosuppressive therapy (IST) is one of the primary therapeutic options; however, some SAA patients ...
Mengzhu Shen +6 more
wiley +1 more source
Paroxysmal nocturnal haemoglobinuria (PNH) is an acquired haemolytic disorder caused by deficient biosynthesis of the glycosyl phosphatidylinositol (GPI) anchor in haemopoietic stem cells.
LIN, LIANG-IN;LIU, CHUN-HAO;CHEN, YAO- CHANG;SHEN, MING-CHING;WANG, CHIU-HWA;HUANG, YI-LING;LIN, JEN-KUN +1 more
core
A rare cause of haemolytic anaemia: paroxysmal nocturnal haemoglobinuria in an elderly patient [PDF]
Paroxysmal nocturnal haemoglobinuria (PNH) is an acquired haemopoietic stem cell disorder characterised clinically by chronic haemolytic anaemia with acute episodes, thrombosis and bone marrow failure.
Baggen, M.G.A. (Marinus) +2 more
core +1 more source
Abstract Evaluation of the pharmacokinetics (PK) of new drugs in Japanese individuals is regularly requested by the Japanese regulatory agency prior to participation in global clinical trials or for bridging approaches for regulatory approval. However, the need for PK assessments in the Japanese population may be less compelling for monoclonal ...
Paridhi Gupta +2 more
wiley +1 more source
Objectives This study investigated outcomes and response to pegcetacoplan in complement inhibitor naïve (CInaïve) and experienced (CIexp) PNH patients.Methods Data were drawn from the Adelphi PNH Disease Specific Programme™, a cross-sectional survey of ...
Jens Panse +9 more
doaj +1 more source

